Michael Gelband’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Michael Gelband’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-80,514	Closed	-$2.18M	–	2212
2024 Q2	$2.18M	Buy	80,514 +39,345	+96%	+$776K	0.01%	745
2024 Q1	$889K	Buy	+41,169	New	+$898K	0.01%	985
2021 Q4	–	Sell	-12,073	Closed	-$107K	–	2833
2021 Q3	$107K	Buy	+12,073	New	+$111K	﹤0.01%	1899
2021 Q2	–	Sell	-15,011	Closed	-$246K	–	3077
2021 Q1	$246K	Buy	+15,011	New	+$245K	﹤0.01%	1779

Other funds holding LBPH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Michael Gelband's LBPH Position: Q3 2024 in Review

Michael Gelband sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q3 2024, closing a stake of 80,514 shares — an estimated $2.18M sold.

Michael Gelband first reported a position in LBPH in Q1 2021 and held it in 4 quarters. The position peaked at $2.18M in Q2 2024. 125 funds tracked by Wall St. Rank hold LBPH as of Q3 2024.

Michael Gelband reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Michael Gelband sold 80,514 Longboard Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $2.18M.
Michael Gelband first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Michael Gelband's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $2.18M in Q2 2024.
125 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.